| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |